U.S. Weightlifting Athlete Rachel Campbell Receives Sanction for Anti-Doping Rule Violation
8th February 2019
USADA announced today that Rachel Campbell, of Alto, N.M., an athlete in the sport of weightlifting, has received a four-year sanction for an anti-doping
rule violation due to her refusal to provide a urine sample.
Campbell, 27, refused to provide a sample as requested by a doping control officer during an
out-of-competition test on November 11, 2018. Evading sample collection, or refusing or failing to submit to sample collection, without compelling justification, is a doping violation under the USADA Protocol for Olympic and Paralympic Movement Testing, the
United States Olympic Committee National Anti-Doping Policies, and the International Weightlifting Federation (IWF) Anti-Doping Policy, all of which have adopted the World Anti-Doping Code (Code) and the WADA Prohibited List.
Campbell’s four-year period of ineligibility began on February 1, 2019, the date her sanction was imposed.
In addition, USADA became aware that Campbell tested positive for a metabolite of oxandrolone as the result of a urine collection administered by the CrossFit
Games on May 17, 2018. Oxandrolone and its metabolites are non-Specified Substances in the class of Anabolic Agents on the WADA Prohibited List.
Due to the circumstances around Campbell’s CrossFit sanction, her refusal was not considered a second violation by USADA, but her results are disqualified from the
time of the positive test. As such, Campbell has been disqualified from all competitive results obtained on and subsequent to May 17, 2018, the date she provided a positive sample to the CrossFit Games, including forfeiture of any medals, points and prizes.
To support a level playing field across various sports and promotions, as was the case here,
USADA encourages other sports organizations who are not Signatories to the Code to publish athlete sanctions, which helps ensure accountability for those athletes who then compete in Olympic or other Code Signatory-sanctioned events.
In an effort to aid athletes, as well as support team members such as parents and coaches, in
understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements (www.Supplement411.org <https://www.supplement411.org/>)
as well as performance-enhancing and recreational drugs. In addition, USADA manages a drug reference hotline, Global Drug Reference Online (www.GlobalDRO.com <https://www.globaldro.com/>),
conducts educational sessions with National Governing Bodies and their athletes, and distributes a multitude of educational materials, such as an easy-reference wallet card with examples of prohibited and permitted substances, a
supplement guide <https://mailchi.mp/22b7a708984d/truesport-supplement-guide>, a nutrition guide <https://www.usada.org/resources/nutrition/>, an athlete handbook, and periodic alerts and advisories.
Along with education and testing, robust anti-doping programs enable investigations stemming
from tips and whistleblowers. USADA makes available a number of ways to report the abuse of performance-enhancing drugs in sport in an effort to protect clean athletes and promote clean competition. Any tip can be reported using the USADA Play
USADA is responsible for the testing and results management process for athletes in the U.S.
Olympic and Paralympic Movement and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.
- Tags: Anti-Doping | International Weightlifting Federation (IWF) | International Weightlifting Federation (IWF) Anti-Doping Policy | United States Anti-Doping Agency (USADA) | United States of America (USA) | Weightlifting